ACTCHEM 85 Date of Issue: 9/22/2015

Safety Data Sheet Supersedes: 1/31/2013

SECTION 1 - PRODUCT AND COMPANY IDENTIFICATION

Product Identifier: ACTCHEM 85
Recommended Use: Refractory Material
Supplier: Artech Technologies, Inc.
Manufacturer: Xertech Specialties LLC
Manufacturer Address: 1422 Hoelzer Ct., Dailey Industrial Park, Pacific, MO 63069
General Phone: (636) 271-0586 Fax: (636) 271-0587
Emergency Phone: (636) 271-0586 7:00-15:00 CST Monday-Friday
SECTION 2 - HAZARDS IDENTIFICATION
GHS/US CLASSIFICATION

GHS-07 GHS-08
Signal Word: Danger
Hazard Statements: Precautionary Statements:
H315 Causes skin irritation P260 Do not breathe dust
H320 Causes eye irritation P264 Wash hands thoroughly after handling
H350 May cause cancer (Inhalation) P270 Do not eat, drink, or smoke when using
this product
H372 Causes damage to lungs through
prolonged or repeated inhalation P280 Wear eye protection, dust respirator,
protective gloves

SECTION 3 – COMPOSITION/INFORMATION ON MIXTURE INGREDIENTS

COMPONENT CAS No. % GHS-US Classification

Aluminum Oxide, Non-Fibrous 1344-28-1 60-100 Not classified
Calcium Aluminate Cement 65997-16-2 5-10 Skin Irrit. 2, H315
Eye Irrit. 2B, H320
Cristobalite 14464-46-1 0.1-1 Carcinogen 1A, H350
STOT RE 1, H372
Silica, Amorphous 69012-64-2 5-10 Skin Irrit. 2, H315
Eye Irrit. 2B, H320

Page 1 of 5
ACTCHEM 85 Date: 9/22/2015
Safety Data Sheet
SECTION 4 – FIRST AID MEASURES
DESCRIPTION OF FIRST AID MEASURES
Inhalation: Move person to fresh air. Call a physician if symptoms develop or persist.
Skin Contact: Wash off with soap and water. Seek medical attention if irritation develops and persists.
Eye Contact: Rinse eyes with water for several minutes. Seek medical attention if irritation develops.
Ingestion: Rinse mouth. Do not induce vomiting. Seek medical attention.
MOST IMPORTANT SYMPTOMS AND EFFECTS, BOTH ACUTE AND DELAYED
Inhalation: May cause cancer by inhalation. Danger of serious damage to health by prolonged
exposure through inhalation.
Skin Contact: Causes skin irritation.
Eye Contact: Causes eye irritation.
INDICATION OF IMMEDIATE MEDICAL ATTENTION AND SPECIAL TREATMENT NEEDED
Treat symptomatically
SECTION 5 – FIRE-FIGHTING MEASURES
EXTINGUISHING MEDIA
Suitable Extinguishing Media: Water spray, dry powder, foam
Unsuitable Extinguishing Media: None known
SPECIAL HAZARDS ARISING FROM THE SUBSTANCE OR MIXTURE
Hazardous Combustion Products: Not combustible. Hydraulic setting.
ADVICE FOR FIREFIGHTERS
Fire Fighting Instructions: Fire-fighters should use standard protective equipment in enclosed spaces,
self-contained breathing apparatus (SCBA).
SECTION 6 – ACCIDENTAL RELEASE MEASURES
PERSONAL PRECAUTIONS, PROTECTIVE EQUIPMENT AND EMERGENCY PROCEDURES
For Non-Emergency Personnel: Ensure area is as well ventilated as possible before tackling spillage.
Avoid contact with skin and eyes. Do not breathe dust.
For Emergency Responders: Do not attempt to take action without suitable protective equipment,
including respiratory protection. For further information, refer to Section 8.
ENVIRONMENTAL PRECAUTIONS
General: Avoid release to the environment.
METHODS AND MATERIALS FOR CONTAINMENT AND CLEANING UP
For Cleaning Up: Sweep or shovel into suitable containers. Minimize generation of dust.
REFERENCE TO OTHER SECTIONS
General: See sections 8 and 13.

Page 2 of 5
ACTCHEM 85 Date: 9/22/2015
Safety Data Sheet
SECTION 7 – HANDLING AND STORAGE
PRECAUTIONS FOR SAFE HANDLING
Do not breathe dust or vapors. Provide good ventilation at all times. Keep out of the reach of children.
Wash contaminated clothing before reuse. Always wash hands after handling the product.
CONDITIONS FOR SAFE STORAGE, INCLUDING ANY INCOMPATIBILITIES
Store this product in original packaging in a dry location where it can be protected from the elements.
SECTION 8 – EXPOSURE CONTROLS AND PERSONAL PROTECTION
CONTROL PARAMETERS
COMPONENT ACGIH TLV OSHA PEL (TWA)
3 3
Aluminum Oxide, Non-Fibrous (1344-28-1) 1 mg/m resp. dust 15 mg/m total
3
5 mg/m resp.
3 3
Calcium Aluminate Cement (65997-16-2) 3 mg/m resp. 10 mg/m total
3 3
10 mg/m inhalable 5 mg/m resp.
3 3
Cristobalite (14464-46-1) 0.025 mg/m resp. 0.05 mg/m resp.
3
Silica, Amorphous (69012-64-2) Withdrawn 80 mg/m SiO2

Notes: TWA - The time-weighted average airborne concentration of a particular substance when
calculated over an eight-hour working day, for a five-day working week.
EXPOSURE CONTROLS
Appropriate Engineering Controls: Ensure adequate ventilation.
Individual Protection Measures, Such As Personal Protective Equipment: Wear appropriate dust mask.
Wear protective gloves. Avoid contact with eyes. Wear goggles, suitable protective clothing, and closed
footwear. Wash hands before eating, drinking, and/or smoking.
SECTION 9 – PHYSICAL AND CHEMICAL PROPERTIES
INFORMATION ON BASIC PHYSICAL AND CHEMICAL PROPERTIES
Physical State: Solid Vapor Pressure: Not applicable
Appearance: Granular mixture Vapor Density (Air = 1): Not applicable
Color: Light grey Relative Density: 2.5
Odor: Earthy odor Solubility: Water: Slight
pH: No data available Partition Coefficient: No data available
Melting Point: >3000 °F Auto-ignition Temp: No data available
Freezing Point: Not applicable Decomposition Temp: No data available
Boiling Point: Not applicable Viscosity: Not applicable
Flash Point: Not applicable Explosive Properties: No data available
Evaporation Rate: Not applicable Oxidizing Properties: No data available
Flammability (solid, gas): Not applicable

Page 3 of 5
ACTCHEM 85 Date: 9/22/2015
Safety Data Sheet
SECTION 10 – STABILITY AND REACTIVITY
REACTIVITY: Product is non-reactive under normal conditions of use, storage, and transport.
CHEMICAL STABILITY: Product is stable under normal conditions.
POSSIBILITY OF HAZARDOUS REACTIONS: No dangerous reactions known during recommended use.
CONDITIONS TO AVOID: Avoid dust formation. Avoid heating in fire.
INCOMPATIBLE MATERIALS: None detailed.
HAZARDOUS DECOMPOSITION PRODUCTS: No additional information available.
SECTION 11 – TOXICOLOGICAL INFORMATION
INFORMATION ON TOXICOLOGICAL EFFECTS
Carcinogenicity:
Cristobalite: IARC Group 1 – Carcinogenic to humans
Amorphous Silica: IARC Group 3 – not classifiable as to its carcinogenicity to humans (ACGIH).
Acute Toxicity:
Cristobalite: Acute Silicosis can occur with exposures to very high concentrations of respirable
crystalline silica over a very short time period, sometimes as short as a few months. The symptoms of
acute silicosis include progressive shortness of breath, fever, cough and weight loss. Acute silicosis is
fatal.
Amorphous Silica: ORAL acute (LD50): 3,160 mg/kg (rat). INTRAVENOUS acute (LD50): 15 mg/kg (Rat).
(RTECS) (2009). Registry of Toxic Effects of Chemical Substances, NIOSH, CDC
Toxicity:
Aluminum Oxide: ORAL (LD50): >10,000 mg/kg (rat)
Cristobalite: Silicosis can occur with the inhalation and retention of respirable crystalline silica dust.
Chronic silicosis can occur after many years of exposure to relatively low levels of airborne respirable
crystalline silica dust. It may be progressive and may develop into complicated silicosis or progressive
massive fibrosis (PMF). Silicosis is characterized by lung lesions shown as radiographic opacities. The
symptoms, if present, are shortness of breath, wheezing, cough and sputum production. Silicosis or PMF
may lead to death. Advanced complicated silicosis or PMF can result in heart disease secondary to the
lung disease.
Amorphous Silica: Tuberculosis
SECTION 12 – ECOLOGICAL INFORMATION
ECOTOXICITY: This product is not considered harmful to aquatic organisms or to cause long-term
adverse effect in the environment.
PERSISTENCE AND DEGRADABILITY: No additional information available
BIOACCUMULATIVE POTENTIAL: No data available
MOBILITY IN SOIL: No data available
OTHER ADVERSE EFFECTS: No adverse effects are expected

Page 4 of 5
ACTCHEM 85 Date: 9/22/2015
Safety Data Sheet
SECTION 13 – DISPOSAL CONSIDERATIONS
WASTE TREATMENT METHODS
Waste Disposal Recommendations: Dispose in a safe manner in accordance with local regulations.
Ecology – Waste Materials: Avoid release to the environment.
SECTION 14 – TRANSPORT INFORMATION
In accordance with DOT, not regulated for transport
This product is not regulated for transport according to ADR/RID/ADN, IMDG, ICAO-TI/IATA-DGR
Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
SECTION 15 – REGULATORY INFORMATION

US STATE REGULATIONS
U.S. California – Proposition 65: This product contains crystalline silica, a chemical known to the state
of California to cause cancer.

INTERNATIONAL REGULATIONS
Cristobalite (14464-46-1): IARC Group 1 (International Agency for Research on Cancer)
Canadian WHMIS Classification: D2A
SECTION 16 – OTHER INFORMATION
ABBREVIATIONS
ACGIH: American Conference of Governmental Industrial Hygienists
DOT: Department of Transportation
IARC: International Agency for Research on Cancer
NIOSH: National Institute for Occupational Safety and Health
OSHA: Occupational Safety and Health Administration
STOT RE 1: Specific Target Organ Toxicity, Repeated Exposure
WHMIS: Workplace Hazardous Materials Information System (Canada)
DISCLAIMER: Reasonable care has been taken in the preparations of the information provided, and it is
believed to be accurate as of the preparation date. However, Artech Technologies LLC and/or Xertech
Specialties LLC make no representation or warranties, and assumes no responsibility as to the
completeness and accuracy thereof. Users must make their own determination as to the suitability of
the product for their purpose prior to use. Artech Technologies LLC and/or Xertech Specialties LLC
assume no liability to any user thereof, nor shall this establish a legally valid contractual relationship to
the product.

Page 5 of 5